Literature DB >> 16052151

Conjunctival Kaposi sarcoma as the initial presentation of human immunodeficiency virus infection.

Theodore H Curtis1, Vikram D Durairaj.   

Abstract

A 34-year-old man presented to the ophthalmology clinic because of an enlarging mass of the left bulbar conjunctiva, found to be Kaposi sarcoma by histologic examination. The patient had no prior diagnosis of human immunodeficiency virus infection, making this one of only two descriptions in the literature of conjunctival Kaposi sarcoma as the initial presentation of human immunodeficiency virus infection. With surgical resection and highly active antiretroviral therapy, the prognosis is good.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052151     DOI: 10.1097/01.iop.0000167783.06103.da

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

Review 1.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

2.  Kaposi's Sarcoma of the Bulbar Conjunctiva in an Immunocompetent Patient.

Authors:  Dimitris Mikropoulos; Ioannis Mavrikakis; Nikolas G Ziakas; Anastasios G P Konstas; Kostas G Boboridis
Journal:  Case Rep Ophthalmol       Date:  2011-06-14

3.  Aggressive conjunctival Kaposi sarcoma as the initial manifestation of acquired immunodeficiency syndrome.

Authors:  Christopher Donovan; Hershel Patel; Sirikishan Shetty; Lauren Bierman; Jay M Lustbader; Aruoriwo M Oboh-Weilke
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-16

4.  Kaposi's sarcoma of the conjunctiva and the eyelid leads to the diagnosis of human immunodeficiency virus infection - a case report.

Authors:  Filipe Sousa Neves; Joana Braga; João Cardoso da Costa; Joaquim Sequeira; Sandra Prazeres
Journal:  BMC Cancer       Date:  2018-07-03       Impact factor: 4.430

Review 5.  Kaposi sarcoma in unusual locations.

Authors:  Liron Pantanowitz; Bruce J Dezube
Journal:  BMC Cancer       Date:  2008-07-07       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.